Evidence map›Paper›PMID 42656970›Full record

ArticleChemical & biomedical imaging2026

Spatiotemporal Imaging Dynamics and Divergent Immune Mechanisms of

Jiajun Liu, Xiao Li, Shuai Xue, Ruitong Hou, Ning Liu, Changjing Zuo, Fengling Shan, Huawei Cai, Biao Li, Danni Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical & biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiajun LiuDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Xiao LiShanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China.ORCID https://orcid.org/0009-0006-0123-4118
Shuai XueShanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China.ORCID https://orcid.org/0009-0003-2150-1939
Ruitong HouKey Laboratory of Radiation Physics and Technology of the Ministry of Education, Institute of Nuclear Science and Technology, Sichuan University, Chengdu 610064, China.
Ning LiuKey Laboratory of Radiation Physics and Technology of the Ministry of Education, Institute of Nuclear Science and Technology, Sichuan University, Chengdu 610064, China.ORCID https://orcid.org/0000-0003-2835-8066
Changjing ZuoDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai 200433, China.ORCID https://orcid.org/0000-0002-2051-766X
Fengling ShanDepartment of Nuclear Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China.
Huawei CaiDepartment of Nuclear Medicine and Clinical Nuclear Medicine Laboratory, West China Hospital, Sichuan University, Chengdu 610041, China.
Biao LiDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Danni LiShanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China.ORCID https://orcid.org/0000-0002-8151-2803

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted alpha therapy (TAT) with Astatine-211 (

Indexed as

211Atimmune responsemolecular imagingtargeted alpha therapythyroid radiotoxicity

Identifiers

PMID42656970
PMCPMC13508524

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.